« Do flies have free will? | Main | Black-market boom for ivory »

'Guardian gene' may hinder some cancer treatments

But having a mutated p53 gene may help ward off tumours after chemotherapy.

A key gene that helps the body to avoid cancer may sometimes hinder cancer treatment, suggest scientists today. On the flipside, the mutated version of the gene, which usually cannot protect against cancer, might work to a patient's advantage during therapy.

Read the story here.

Posted by Nicola Jones on May 16, 2007
Categories: | | Comments (0) | TrackBacks (0)

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/2569

Post a comment

Comments will be reviewed by staff before being published. You can be as critical or controversial as you like, but please don't get personal or offensive, and do keep it brief. Excessively long entries may be cropped. Remember this is for feedback and discussion - not for publishing papers or press releases.

We strongly encourage you to use your real, full name. Email addresses are required: this is just in case we need to discuss your comment with you privately. They won’t be published.


Please enter the numbers you see below - this helps us to cut down on spam. Note that attempting to post within 30 seconds of hitting ‘preview’ or ‘post’ can cause the system to think you are spamming the site. If you are having trouble with this system, you can instead e-mail a comment to 'inthefield at nature.com'.

Search